US Stock MarketDetailed Quotes

Foghorn Therapeutics (FHTX)

Watchlist

5.780
+0.110+1.94%

Trading Feb 25 13:52 ET

338.60MMarket Cap-5.07P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Foghorn Therapeutics (FHTX) Key Financial Indicators

FHTX Free Cash Flow (FCF)

Interested in knowing about Foghorn Therapeutics's free cash flow? The latest report shows it as -18.86M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

FHTX Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Foghorn Therapeutics shows that the company's current ratio is 2.16, indicating healthy liquidity.

Currency: USD

Quarterly

FHTX Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Foghorn Therapeutics, the quick ratio is 2.12, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

FHTX Return on Equity (ROE)

Want to learn more about the financial health of Foghorn Therapeutics? The latest ROE figure is -236.43%, indicating that the company has stable profitability.

Currency: USD

Quarterly

FHTX Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Foghorn Therapeutics, the total asset return on investment (ROA) is -7.35%.

Currency: USD

Quarterly

FHTX Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Foghorn Therapeutics's latest financial report to see how their gross margin is doing - currently at --.

Currency: USD

Quarterly

FHTX Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Foghorn Therapeutics, the net profit margin is -194.39%, which is a good sign for its profitability.

Currency: USD

Quarterly